IL‐21 promotes the production of anti‐DNA IgG but is dispensable for kidney damage in lyn−/− mice

The autoimmune disease systemic lupus erythematosus is characterized by loss of tolerance to nuclear Ags and a heightened inflammatory environment, which together result in end organ damage. Lyn‐deficient mice, a model of systemic lupus erythematosus, lack an inhibitor of B‐cell and myeloid cell activation. This results in B‐cell hyper‐responsiveness, plasma cell accumulation, autoantibodies, and glomerulonephritis (GN). IL‐21 is associated with autoimmunity in mice and humans and promotes B‐cell differentiation and class switching. Here, we explore the role of IL‐21 in the autoimmune phenotypes of lyn–/– mice. We find that IL‐21 mRNA is reduced in the spleens of lyn–/–IL‐6–/– and lyn–/–Btklo mice, neither of which produce pathogenic autoantibodies or develop significant GN. While IL‐21 is dispensable for plasma cell accumulation and IgM autoantibodies in lyn–/– mice, it is required for anti‐DNA IgG antibodies and some aspects of T‐cell activation. Surprisingly, GN still develops in lyn–/–IL‐21–/– mice. This likely results from the presence of IgG autoantibodies against a limited set of non‐DNA Ags. These studies identify a specific role for IL‐21 in the class switching of anti‐DNA B cells and demonstrate that neither IL‐21 nor anti‐DNA IgG is required for kidney damage in lyn–/– mice.

[1]  S. Nutt,et al.  The development and fate of follicular helper T cells defined by an IL-21 reporter mouse , 2012, Nature Immunology.

[2]  Yijun Carrier,et al.  IL-21 Receptor Is Required for the Systemic Accumulation of Activated B and T Lymphocytes in MRL/MpJ-Faslpr/lpr/J Mice , 2012, The Journal of Immunology.

[3]  E. Zúñiga,et al.  Late Interleukin-6 Escalates T Follicular Helper Cell Responses and Controls a Chronic Viral Infection , 2011, Science.

[4]  A. Cunningham,et al.  B cell priming for extrafollicular antibody responses requires Bcl-6 expression by T cells , 2011, The Journal of Experimental Medicine.

[5]  E. Bottinger,et al.  A Unique Hybrid Renal Mononuclear Phagocyte Activation Phenotype in Murine Systemic Lupus Erythematosus Nephritis , 2011, The Journal of Immunology.

[6]  Burton E. Barnett,et al.  IL-21 and IL-6 Are Critical for Different Aspects of B Cell Immunity and Redundantly Induce Optimal Follicular Helper CD4 T Cell (Tfh) Differentiation , 2011, PloS one.

[7]  M. Bachmann,et al.  IL-21 induces death of marginal zone B cells during chronic inflammation. , 2010, Blood.

[8]  Irah L. King,et al.  A Nonredundant Role for IL-21 Receptor Signaling in Plasma Cell Differentiation and Protective Type 2 Immunity against Gastrointestinal Helminth Infection , 2010, The Journal of Immunology.

[9]  A. DeFranco,et al.  Myeloid cells, BAFF, and IFN-γ establish an inflammatory loop that exacerbates autoimmunity in Lyn-deficient mice , 2010, The Journal of experimental medicine.

[10]  S. Kaech,et al.  In Vivo Regulation of Bcl6 and T Follicular Helper Cell Development , 2010, Journal of Immunology.

[11]  Quanzhen Li,et al.  Separate checkpoints regulate splenic plasma cell accumulation and IgG autoantibody production in Lyn‐deficient mice , 2010, European journal of immunology.

[12]  A. Kimura,et al.  IL‐6: Regulator of Treg/Th17 balance , 2010, European journal of immunology.

[13]  G. Illei,et al.  BASOPHILS AND THE T HELPER 2 ENVIRONMENT CAN PROMOTE THE DEVELOPMENT OF LUPUS NEPHRITIS , 2010, Nature Medicine.

[14]  K. Toellner,et al.  IL-21 regulates germinal center B cell differentiation and proliferation through a B cell–intrinsic mechanism , 2010, The Journal of experimental medicine.

[15]  M. Linterman,et al.  IL-21 acts directly on B cells to regulate Bcl-6 expression and germinal center responses , 2010, The Journal of experimental medicine.

[16]  P. Lipsky,et al.  Tocilizumab in systemic lupus erythematosus: data on safety, preliminary efficacy, and impact on circulating plasma cells from an open-label phase I dosage-escalation study. , 2010, Arthritis and rheumatism.

[17]  P. Galle,et al.  Interleukin 6 (IL-6) Deficiency Delays Lupus Nephritis in MRL-Faslpr Mice: The IL-6 Pathway as a New Therapeutic Target in Treatment of Autoimmune Kidney Disease in Systemic Lupus Erythematosus , 2010, The Journal of Rheumatology.

[18]  C. Quilici,et al.  Autoimmune Disease in Lyn-Deficient Mice Is Dependent on an Inflammatory Environment Established by IL-6 , 2009, The Journal of Immunology.

[19]  C. Quilici,et al.  Perturbation of the CD4 T Cell Compartment and Expansion of Regulatory T Cells in Autoimmune-Prone Lyn-Deficient Mice1 , 2009, The Journal of Immunology.

[20]  P. Gaffney,et al.  A polymorphism within IL21R confers risk for systemic lupus erythematosus. , 2009, Arthritis and rheumatism.

[21]  C. Mohan,et al.  Three checkpoints in lupus development: central tolerance in adaptive immunity, peripheral amplification by innate immunity and end-organ inflammation , 2009, Genes and Immunity.

[22]  K. Coggeshall,et al.  Interleukin-6 aborts lymphopoiesis and elevates production of myeloid cells in systemic lupus erythematosus-prone B6.Sle1.Yaa animals. , 2009, Blood.

[23]  P. Gaffney,et al.  Genetic associations of LYN with systemic lupus erythematosus , 2009, Genes and Immunity.

[24]  M. Cook,et al.  Follicular helper T cells are required for systemic autoimmunity , 2009, The Journal of experimental medicine.

[25]  W. Leonard,et al.  Interleukin-6/STAT3 signaling regulates the ability of naive T cells to acquire B-cell help capacities. , 2009, Blood.

[26]  W. Leonard,et al.  A critical role for IL-21 receptor signaling in the pathogenesis of systemic lupus erythematosus in BXSB-Yaa mice , 2009, Proceedings of the National Academy of Sciences.

[27]  G. Ciliberto,et al.  The induction of antibody production by IL-6 is indirectly mediated by IL-21 produced by CD4+ T cells , 2009, The Journal of experimental medicine.

[28]  R. Flavell,et al.  ICOS-dependent extrafollicular helper T cells elicit IgG production via IL-21 in systemic autoimmunity , 2008, The Journal of experimental medicine.

[29]  S. Tangye,et al.  IL-21-Induced Isotype Switching to IgG and IgA by Human Naive B Cells Is Differentially Regulated by IL-41 , 2008, The Journal of Immunology.

[30]  C. Mackay,et al.  A fundamental role for interleukin-21 in the generation of T follicular helper cells. , 2008, Immunity.

[31]  D. Hwang,et al.  Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages. , 2008, Immunity.

[32]  Thomas D. Schmittgen,et al.  Analyzing real-time PCR data by the comparative CT method , 2008, Nature Protocols.

[33]  Marta E Alarcón-Riquelme,et al.  Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci , 2008, Nature Genetics.

[34]  Y. Li,et al.  Cytokine-Mediated Regulation of Human B Cell Differentiation into Ig-Secreting Cells: Predominant Role of IL-21 Produced by CXCR5+ T Follicular Helper Cells1 , 2007, The Journal of Immunology.

[35]  P. Lipsky,et al.  Essential Role of IL-21 in B Cell Activation, Expansion, and Plasma Cell Generation during CD4+ T Cell-B Cell Collaboration1 , 2007, The Journal of Immunology.

[36]  P. Lipsky,et al.  Genetic association of interleukin-21 polymorphisms with systemic lupus erythematosus , 2007, Annals of the rheumatic diseases.

[37]  T. Naka,et al.  IL-6-dependent and -independent pathways in the development of interleukin 17-producing T helper cells , 2007, Proceedings of the National Academy of Sciences.

[38]  M. Collins,et al.  IL-21 Has a Pathogenic Role in a Lupus-Prone Mouse Model and Its Blockade with IL-21R.Fc Reduces Disease Progression , 2007, The Journal of Immunology.

[39]  N. Olsen,et al.  Protein array autoantibody profiles for insights into systemic lupus erythematosus and incomplete lupus syndromes , 2006, Clinical and experimental immunology.

[40]  J. Zavadil,et al.  Nephritogenic anti-DNA antibodies regulate gene expression in MRL/lpr mouse glomerular mesangial cells. , 2006, Arthritis and rheumatism.

[41]  Quanzhen Li,et al.  A Tlr7 translocation accelerates systemic autoimmunity in murine lupus. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[42]  P. Lipsky,et al.  IL-21 Induces Differentiation of Human Naive and Memory B Cells into Antibody-Secreting Plasma Cells1 , 2005, The Journal of Immunology.

[43]  D. Isenberg,et al.  Decreased Lyn expression and translocation to lipid raft signaling domains in B lymphocytes from patients with systemic lupus erythematosus. , 2005, Arthritis and rheumatism.

[44]  R. Copley,et al.  A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity , 2005, Nature.

[45]  D. Foster,et al.  Cutting Edge: IL-21 Is a Switch Factor for the Production of IgG1 and IgG3 by Human B Cells1 , 2004, The Journal of Immunology.

[46]  Chandra Mohan,et al.  Strain Distribution Pattern of Susceptibility to Immune-Mediated Nephritis1 , 2004, The Journal of Immunology.

[47]  K. Takatsu,et al.  Abrogation of autoimmune disease in Lyn-deficient mice by the deletion of IL-5 receptor alpha chain gene. , 2004, Cellular immunology.

[48]  J. Burnside,et al.  Microarray Analysis of Lyn-Deficient B Cells Reveals Germinal Center-Associated Nuclear Protein and Other Genes Associated with the Lymphoid Germinal Center1 , 2004, The Journal of Immunology.

[49]  Kelvin Hsu,et al.  Pathogenic Profiles and Molecular Signatures of Antinuclear Autoantibodies Rescued from NZM2410 Lupus Mice , 2004, The Journal of experimental medicine.

[50]  A. Satterthwaite,et al.  Reduced Dosage of Bruton’s Tyrosine Kinase Uncouples B Cell Hyperresponsiveness from Autoimmunity in lyn−/− Mice1 , 2003, The Journal of Immunology.

[51]  A. Sher,et al.  A Critical Role for IL-21 in Regulating Immunoglobulin Production , 2002, Science.

[52]  Nitin J. Karandikar,et al.  Glatiramer acetate (Copaxone) therapy induces CD8(+) T cell responses in patients with multiple sclerosis. , 2002, The Journal of clinical investigation.

[53]  J. Erikson,et al.  Novel Roles for Lyn in B Cell Migration and Lipopolysaccharide Responsiveness Revealed Using Anti-Double-Stranded DNA Ig Transgenic Mice1 , 2001, The Journal of Immunology.

[54]  M. Dimopoulos,et al.  B-Cell Kinase Lyn Deficiency in Patients With Systemic Lupus Erythematosus , 2001, Journal of Investigative Medicine.

[55]  N. Vaziri,et al.  Association of Renal Injury with Increased Oxygen Free Radical Activity and Altered Nitric Oxide Metabolism in Chronic Experimental Hemosiderosis , 2000, Laboratory Investigation.

[56]  F. Alt,et al.  Independent and Opposing Roles For Btk and Lyn in B and Myeloid Signaling Pathways , 1998, The Journal of experimental medicine.

[57]  N. Motoyama,et al.  Affinity maturation in Lyn kinase-deficient mice with defective germinal center formation. , 1998, Journal of immunology.

[58]  I. Taniuchi,et al.  Abrogation of autoimmune disease in Lyn-deficient mice by the mutation of the Btk gene. , 1998, International immunology.

[59]  Philippe Soriano,et al.  Characterization of the B lymphocyte populations in Lyn-deficient mice and the role of Lyn in signal initiation and down-regulation. , 1997, Immunity.

[60]  N. Smith,et al.  IL‐6 acts on endothelial cells to preferentially increase their adherence for lymphocytes , 1996, Clinical and experimental immunology.

[61]  T. Yamamoto,et al.  Impaired proliferation of peripheral B cells and indication of autoimmune disease in lyn-deficient mice. , 1995, Immunity.

[62]  S. Stacker,et al.  Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease , 1995, Cell.

[63]  E. Wakeland,et al.  Systemic lupus erythematosus: multiple immunological phenotypes in a complex genetic disease. , 2006, Advances in immunology.

[64]  M. Hibbs,et al.  Lyn tyrosine kinase: accentuating the positive and the negative. , 2005, Immunity.